Klin Farmakol Farm. 2006;20(2):71-74

Current treatment options for infections caused by resistant gram-positive bacteria

doc. MUDr. Milan Kolář PhD1, MUDr. Karel Urbánek Ph.D2, Pavel Dlouhý3
1 Ústav mikrobiologie FN a LF UP v Olomouci
2 Ústav farmakologie LF UP a FN Olomouc
3 Infekční oddělení, Masarykova nemocnice, Ústí nad Labem

The paper discusses how infections caused by resistant gram-positive bacteria could be treated. Also reported are the proportions of staphylococci and enterococci among the most common infections in patients hospitalized in the Teaching Hospital in Olomouc. Based on the surveillance of bacterial resistance possible approaches to antibiotherapy are suggested.

Keywords: gram-positive bacteria, resistance, antibiotic therapy

Published: September 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář M, Urbánek K, Dlouhý P. Current treatment options for infections caused by resistant gram-positive bacteria. Klin Farmakol Farm. 2006;20(2):71-74.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Murdoch DR, Mirrett S, Harrell LJ, Monahan JS, Reller LB. Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. Antimicrob Agents Chemother 2002; 46: 3676-3678. Go to original source... Go to PubMed...
    2. Petráš P. Koaguláza-negativní stafylokoky u infekcí krevního řečiště. In: Kolář M, Látal T. Antibiotická politika - vybrané kapitoly. Trios, Praha, 2002.
    3. Pfaller MA, Jones RN, Doern GV, Kugler K, and the SENTRY participants group. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-1770. Go to original source... Go to PubMed...
    4. Isenberg HD. Clinical microbiology procedures handbook. ASM Press, Washington D.C., 2004.
    5. Krieg NR, Holt JG, et al. (eds). Bergey´s Manual of Systematic Bacteriology, Vol. 1. The Williams and Wilkins Co., Baltimore, 1994.
    6. Urbášková P. Rezistence bakterií k antibiotikům - vybrané metody. Trios, Praha, 1998.
    7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-S12. NCCLS, Wayne, Pennsylvania, 2002.
    8. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602. Go to original source... Go to PubMed...
    9. Luzzaro F, Viganň EF, Fossati D, et al. Prevalence and drug suceptibility of pathogens causing bloodstream infections in nothern Italy: A two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis 2002; 21: 849-855. Go to original source...
    10. Jones RN, Low DE, Pfaller MA. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds. Diagn Microbiol Infect Dis 1999; 33: 101-112. Go to original source... Go to PubMed...
    11. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-892. Go to original source... Go to PubMed...
    12. Kolář M, Heinigeová B, Bartoníková N, et al. Grampozitivní patogeny při infekcích krevního řečiště - multicentrická studie. Klin Mikrobiol Inf Lék 2003; 9: 244-252.
    13. Gelsomino R, Vancanneyt M, Cogan TM, Swings J. Effect of raw-milk cheese consumption on the enterococcal flora of human feces. Appl Environ Microb 2003; 69: 312-319. Go to original source... Go to PubMed...
    14. Hájek V, Součková A. Grampozitivní koky. In: Bednář M, Fraňková V, Schindler J, Souček A, Vávra J. Lékařská mikrobiologie. Marvil, Praha, 1996.
    15. Votava M, a kol. Lékařská mikrobiologie speciální. Neptun, Brno, 2003.
    16. Watanakunakorn C. Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin. J Antimicrob Chemother 1990; 26: 602-604. Go to original source... Go to PubMed...
    17. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl. 2): S133-S145. Go to original source... Go to PubMed...
    18. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-222. Go to original source... Go to PubMed...
    19. Kolář M, Vágnerová I, Kohnová I. Záchyt vankomycin - rezistentních enterokoků ve Fakultní nemocnici v Olomouci. Klin Mikrobiol Inf Lék 1997; 3: 189-191.
    20. Bergerová T, Turková S. První vankomycin-rezistentní enterokoky ve FN v Plzni. Klin Mikrobiol Inf Lék 1997; 3: 287-288.
    21. Hanslianová T, Burgetová D. Diskuzní příspěvek k článku, ,Záchyt vankomycin-rezistentních enterokoků ve Fakultní nemocnici v Olomouci". Klin Mikrobiol Inf Lék 1997; 9: 256.
    22. European Antimicrobial Resistance Surveillance System. EARSS interactive database access. National Institute of Public Health and Environment, Bilthoven, (www.earss.rivm.nl).
    23. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998; 42: 3251-3255. Go to original source... Go to PubMed...
    24. Hill RLR, Smith CT, Seyed-Akhavani M, et al. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycinand gentamicin-resistant Enterococcus faecium. J Antimicrob Chemother 1997; 39 (Suppl A): 23-28. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.